Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical Observation

Aim. A clinical case description to highlight challenges in diagnosing MALT lymphoma presented in infiltrative ulcer-ative lesions.Key points. A 60-yo patient was admitted to the Loginov Moscow Clinical Scientific Centre with epigastric pain and an 18 kg weight loss over past 4 months. A history of...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Ya. Selezneva, N. A. Shcherbakova, Yu. V. Embutnieks, E. V. Bystrovskaya, S. G. Khomeriki
Format: Article
Language:Russian
Published: Gastro LLC 2021-10-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/521
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860146536710144
author E. Ya. Selezneva
N. A. Shcherbakova
Yu. V. Embutnieks
E. V. Bystrovskaya
S. G. Khomeriki
author_facet E. Ya. Selezneva
N. A. Shcherbakova
Yu. V. Embutnieks
E. V. Bystrovskaya
S. G. Khomeriki
author_sort E. Ya. Selezneva
collection DOAJ
description Aim. A clinical case description to highlight challenges in diagnosing MALT lymphoma presented in infiltrative ulcer-ative lesions.Key points. A 60-yo patient was admitted to the Loginov Moscow Clinical Scientific Centre with epigastric pain and an 18 kg weight loss over past 4 months. A history of repeated outpatient endoscopic examinations revealing subse-quently ulcerative and infiltrative ulcerative gastric lesions of unestablished origin. A complex examination combin-ing oesophagogastroduodenoscopy (OGDS), endosonography (EUS), multislice computed tomography (MSCT), morphological and immunohistochemical (IHC) assays elicited the MALT gastric lymphoma IIE stage involving para-gastric and intraperitoneal lymph nodes. The first treatment stage included line-1 eradication therapy, rabeprazole 20 mg x 2 times a day, amoxicillin 1000 mg x 2 times a day, clarithromycin 500 mg x 2 times a day, bismuth tripotas-sium dicitrate 240 mg x 2 times a day — for 14 days. Accounting for the process prevalence and stage, six courses of R-CHOP polychemotherapy (PCT) were ordered by haematologist.Conclusion. This observation demonstrates a targeted-biopsy endoscopic examination followed by morphological, IHC, EUS (for invasion depth) and MSCT (for process advancement) assays to be decisive in differential diagnosis of ulcerative and infiltrative ulcerative gastric lesions.
format Article
id doaj-art-9c736f30c7424153a5cb21f4f931b6db
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2021-10-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-9c736f30c7424153a5cb21f4f931b6db2025-02-10T16:14:36ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732021-10-01313606710.22416/1382-4376-2021-31-3-60-67430Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical ObservationE. Ya. Selezneva0N. A. Shcherbakova1Yu. V. Embutnieks2E. V. Bystrovskaya3S. G. Khomeriki4Loginov Moscow Clinical Scientific CentreLoginov Moscow Clinical Scientific CentreLoginov Moscow Clinical Scientific CentreLoginov Moscow Clinical Scientific CentreLoginov Moscow Clinical Scientific CentreAim. A clinical case description to highlight challenges in diagnosing MALT lymphoma presented in infiltrative ulcer-ative lesions.Key points. A 60-yo patient was admitted to the Loginov Moscow Clinical Scientific Centre with epigastric pain and an 18 kg weight loss over past 4 months. A history of repeated outpatient endoscopic examinations revealing subse-quently ulcerative and infiltrative ulcerative gastric lesions of unestablished origin. A complex examination combin-ing oesophagogastroduodenoscopy (OGDS), endosonography (EUS), multislice computed tomography (MSCT), morphological and immunohistochemical (IHC) assays elicited the MALT gastric lymphoma IIE stage involving para-gastric and intraperitoneal lymph nodes. The first treatment stage included line-1 eradication therapy, rabeprazole 20 mg x 2 times a day, amoxicillin 1000 mg x 2 times a day, clarithromycin 500 mg x 2 times a day, bismuth tripotas-sium dicitrate 240 mg x 2 times a day — for 14 days. Accounting for the process prevalence and stage, six courses of R-CHOP polychemotherapy (PCT) were ordered by haematologist.Conclusion. This observation demonstrates a targeted-biopsy endoscopic examination followed by morphological, IHC, EUS (for invasion depth) and MSCT (for process advancement) assays to be decisive in differential diagnosis of ulcerative and infiltrative ulcerative gastric lesions.https://www.gastro-j.ru/jour/article/view/521malt gastric lymphomah. pylorieradication therapy conflict of interest: the authors declare no conflict of interest
spellingShingle E. Ya. Selezneva
N. A. Shcherbakova
Yu. V. Embutnieks
E. V. Bystrovskaya
S. G. Khomeriki
Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical Observation
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
malt gastric lymphoma
h. pylori
eradication therapy conflict of interest: the authors declare no conflict of interest
title Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical Observation
title_full Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical Observation
title_fullStr Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical Observation
title_full_unstemmed Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical Observation
title_short Diagnosing MALT Gastric Lymphoma in Gastroenterologist’s Practice, a Clinical Observation
title_sort diagnosing malt gastric lymphoma in gastroenterologist s practice a clinical observation
topic malt gastric lymphoma
h. pylori
eradication therapy conflict of interest: the authors declare no conflict of interest
url https://www.gastro-j.ru/jour/article/view/521
work_keys_str_mv AT eyaselezneva diagnosingmaltgastriclymphomaingastroenterologistspracticeaclinicalobservation
AT nashcherbakova diagnosingmaltgastriclymphomaingastroenterologistspracticeaclinicalobservation
AT yuvembutnieks diagnosingmaltgastriclymphomaingastroenterologistspracticeaclinicalobservation
AT evbystrovskaya diagnosingmaltgastriclymphomaingastroenterologistspracticeaclinicalobservation
AT sgkhomeriki diagnosingmaltgastriclymphomaingastroenterologistspracticeaclinicalobservation